Cipher Pharmaceuticals Inc
SWB:PHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cipher Pharmaceuticals Inc
SWB:PHE
|
CA |
|
U
|
US Physical Therapy Inc
F:UPH
|
US |
|
G
|
Greif Inc
F:GR3
|
US |
|
Barrick Mining Corp
SIX:B
|
CA |
|
Maxlinear Inc
NASDAQ:MXL
|
US |
|
P
|
Proto Labs Inc
XMUN:PRZ
|
US |
|
MLP SE
F:MLP
|
DE |
|
K
|
Kingspan Group PLC
F:KRX
|
IE |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
N
|
Netflix Inc
F:NFC
|
US |
|
F
|
Fortec Elektronik AG
XMUN:FEV
|
DE |
Shareholder Yield
Current shareholder yield for 
PHE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
PHE Price
Cipher Pharmaceuticals Inc
| Average Annual Return | 82.21% |
| Standard Deviation of Annual Returns | 58.73% |
| Max Drawdown | -46% |
| Market Capitalization | 438.1m EUR |
| Shares Outstanding | 5 482 029 |
| Percentage of Shares Shorted |
N/A
|
